The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012

Surgical management of neuroendocrine tumor-associated liver metastases: a review

Liver metastasis is common among patients who suffer from neuroendocrine tumors (NETs). Radical surgery is the standard treatment whenever possible but there is still controversies concerning the treatment strategies such as resection of the primary, role of debulking surgery, liver transplantation (LT) and neoadjuvant or adjuvant therapies. This article aims to review the current evidence available, together with some latest updates, focusing on the surgical management.

Hepatic metastasis of a parathyroid carcinoma treated with intra-arterial embolization

Se reporta el caso de una paciente con carcinoma de paratiroides metastásico al hígado con hipercalcemia de muy difícil control pese a manejo con ácido Zoledrónico y Cinacalcet. La paciente fue llevada a embolización intraarterial con microesferas de alcohol polivinílico de la arteria hepática derecha, con lo que se obtuvo un excelente control bioquímico después de la intervención.

Catheter-based treatments for hepatic metastases from neuroendocrine tumors

OBJECTIVE

The purpose of this article is to present our experience in treating patients with hepatic metastases from a neuroendocrine primary malignancy.

CONCLUSION

The tumor and patient characteristics, vascular access, and features of treatment all play a role in the long-term management of patients with metatastic neuroendocrine tumors. Routine prophylactic measures are recommended to reduce the frequency and severity of crisis events related to hormone release in patients with neuroendocrine tumors.